Equities

Kobayashi Pharmaceutical Co Ltd

Kobayashi Pharmaceutical Co Ltd

Actions
  • Price (EUR)34.00
  • Today's Change0.80 / 2.41%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024 18:31 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments79,836104,533109,046
Total Receivables, Net52,98447,85355,147
Total Inventory22,08117,67815,107
Prepaid expenses------
Other current assets, total3,4302,8282,589
Total current assets158,331172,892181,889
Property, plant & equipment, net47,66534,77822,524
Goodwill, net9,6557,1477,189
Intangibles, net11,9596,1605,469
Long term investments34,80231,21632,201
Note receivable - long term1,132975816
Other long term assets990909977
Total assets267,473255,827252,554
LIABILITIES
Accounts payable17,30518,05617,444
Accrued expenses3,4933,4743,125
Notes payable/short-term debt001.00
Current portion long-term debt/capital leases379261169
Other current liabilities, total34,93430,01829,964
Total current liabilities56,11151,80950,703
Total long term debt608531460
Total debt987792630
Deferred income tax2,5941,3101,564
Minority interest------
Other liabilities, total3,3444,2774,227
Total liabilities62,65757,92756,954
SHAREHOLDERS EQUITY
Common stock3,4503,4503,450
Additional paid-in capital5225224,183
Retained earnings (accumulated deficit)206,127194,545200,587
Treasury stock - common(24766)(14482)(23706)
Unrealized gain (loss)12,81910,34610,953
Other equity, total6,6643,519133
Total equity204,816197,900195,600
Total liabilities & shareholders' equity267,473255,827252,554
Total common shares outstanding747678
Treasury shares - common primary issue3.712.044.31
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.